(MedPage Today) — The investigational neuroplastogen TSND-201 showed significant efficacy in patients with severe post-traumatic stress disorder (PTSD), according to results from a phase II randomized trial.
Among 65 patients, treatment with…
Source link : https://www.medpagetoday.com/psychiatry/anxietystress/119935
Author :
Publish date : 2026-02-18 20:52:00
Copyright for syndicated content belongs to the linked Source.
